Barrett Esophagus Clinical Trial
Official title:
Non-invasive Testing for the Diagnosis of Early Oesophageal Cancer and Barrett's Dysplasia
This study aims to determine whether a breath test could be used for early detection of oesophageal cancer and Barrett's high grade dysplasia. Patients who are attending for a planned gastroscopy or who are scheduled to undergo elective resection of histologically confirmed early stage oesophageal adenocarcinoma or dysplasia will be approached to provide a breath sample. Multi platform mass spectrometry analysis will be performed to establish volatile biomarkers that can discriminate between early stage (T1) oesophageal cancer/ Hight grade dysplasia from non cancer healthy controls/non dysplastic Barrett's cancer.
The incidence of oesophageal adenocarcinoma has been rising over the last decade. Despite improvements in oncological and surgical therapies the associated survival remains poor, mainly due to delays in diagnosis and advanced stage at presentation. Identifying patients at earlier stages as well as those at risk of cancer may lead to survival benefit. Barrett's oesophagus is an established risk factor for the development of oesophageal adenocarcinoma. It has an established histopathologic progression from low-grade, through high-grade dysplasia (HGD) to oesophageal adenocarcinoma (OAC). Barrett's oesophagus patients currently undergo regular endoscopic surveillance to allow earlier detection of oesophageal cancer. The primary objective is to evaluate the diagnostic accuracy and clinical utility of the volatile organic compounds (VOC) in exhaled breath to detect early stage oesophageal adenocarcinoma and high-grade dysplastic Barrett's oesophagus. All patients will be fasted for a minimum of 6 hours prior to the breath sample as part of their routine clinical care. Breath collection will be conducted using a previously validated method. Samples of breath (500ml) collected using "breath collecting device utilising bags". Breath samples collected within thermal desorption tubes (Markes International, Llantrisant, UK) will be transferred to a central laboratory for analysis by gas chromatography mass spectrometry (GC-MS) and proton transfer reaction time of flight mass spectrometry (PTR-ToF-MS). Raw data files will be extracted and analysed in accordance with established protocols. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03554356 -
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
|
N/A | |
| Completed |
NCT03015389 -
Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma
|
||
| Completed |
NCT03434834 -
OCT Pilot in Esophagus
|
N/A | |
| Terminated |
NCT04642690 -
Nitrates and IL-8 in Barrett's Esophagus
|
||
| Recruiting |
NCT03468634 -
Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy
|
N/A | |
| Recruiting |
NCT02310230 -
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
|
N/A | |
| Completed |
NCT00217087 -
Endoscopic Therapy of Early Cancer in Barretts Esophagus
|
Phase 2 | |
| Completed |
NCT02284802 -
Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy
|
N/A | |
| Recruiting |
NCT05530343 -
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
|
N/A | |
| Active, not recruiting |
NCT04151524 -
Classification of Adenocarcinoma of the Esophagogastric Junction
|
||
| Completed |
NCT00955019 -
Novel Method of Surveillance in Barrett's Esophagus
|
Phase 2 | |
| Terminated |
NCT00386594 -
Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
|
N/A | |
| Completed |
NCT00576498 -
Novel Imaging Techniques in Barrett's Esophagus
|
N/A | |
| Completed |
NCT02688114 -
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
|
N/A | |
| Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
| Completed |
NCT02560623 -
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
|
N/A | |
| Recruiting |
NCT05056051 -
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
|
N/A | |
| Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
| Completed |
NCT04587310 -
Does Laparoscopic Sleeve Gastrectomy Lead to Barrett's Esophagus, 5-year Esophagogastroduodenoscopy Findings: A Retrospective Cohort Study
|
||
| Recruiting |
NCT05107219 -
GCC Agonist Signal in the Small Intestine
|
Phase 1 |